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INTRODUCTION:
The World Health Organization (WHO) estimated that infections accounted for 45% of deaths in Africa and South-East Asia and were responsible for 48% of premature deaths worldwide, bacterial infection accounted for a significant proportion of these infections in Africa [1] . The valuable life spans of most antibiotics used in treating these infections have been diminished by the development of resistant strains. Microorganisms use a combination of mechanisms in developing resistance however a dominant mechanism may be identifiable [2, 3] . The relationship between antibiotic use and resistance is complex; a major driving factor for antibiotic resistance is antibiotic use/abuse both within medicine and veterinary medicine. In Nigeria 53% of respondents in a survey took incomplete regimen of antibiotics, a significant proportion of which were self prescribed for unspecified ailments [4, 5] .
Antibiotic resistance increasingly compromises the outcome of many infections that were, until recently, treatable and remain the most common diseases in Africa [6] . The global problem of antimicrobial resistance is particularly pressing in developing countries, where the infectious disease burden is high and cost constraints prevent the widespread application of newer, more expensive agents [6] . Reports from multiple studies from different parts of Nigeria though have observed temporal trends in the prevalence of resistance among enteric organisms have shown increasing prevalence in the last fifteen years [7] .
High prevalence of multidrug resistance indicates a serious need for broad-based, local antimicrobial resistance surveillance and planning of effective interventions to reduce multidrug resistance in such pathogens [8] . Multiple antibiotic resistance (MAR) in bacteria is most commonly associated with the presence of plasmids which contain one or more resistance genes, each encoding a single antibiotic resistance phenotype [9] .
Emergence of antibiotic resistance in P. aeruginosa resulting in severe adverse outcomes had been on the rise. In the USA annual prevalence of fluoroquinolones and imipenem resistant P. aeruginosa increased from 15% in 1991 to 41% in 2000 1%, and from 1989 to 2006 from 13% to 20% respectively [10] . In Lagos, similar results have been previously documented [11] . These same conclusions had been drawn in Zaria though P. aeruginosa there were more susceptible to fluoroquinolones [9] . In Zaria and Enugu about 60 % , 42%, 33% of clinical isolates of Pseudomonas spp, Escherichia spp, and Klebsiella spp respectively were noted to be multidrug resistant [12] . In Enugu and Abakaliki 62% of Klebsiella isolates were ESBL producers.
Multiple antibiotic resistance (MAR) indexing has been shown to be a cost effective and valid method of bacteria source tracking. Multiple antibiotic resistance index is calculated as the ratio of number of resistant antibiotics to which organism is resistant to total number of antibiotics to which organism is exposed [13, 14] Apart from general caution to strictly follow procedures as described in manufacturer's manual, Pseudomonas aeruginosa ATCC 2785 and Escherichia coli ATCC 25922 were used as positive and negative controls respectively. MAR index was determined by following the procedure described by Krumperman 1983 [14] . A MAR index for an isolate is calculated as: Number of antibiotics to which isolate is resistant/ Total number of antibiotics against which isolate was tested. (14) while those with MAR index less than 0.2 was 33.3% (7) showing that a greater proportion of the isolates are likely to be from a high risk source. The MAR index of the Klebsiella sample was 0.4. Blue bars represent proportion that is sensitive; Red bars represent proportion that is resistant.
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High prevalence of multidrug resistance indicate serious need for antibiotics surveillance program. Multiple antibiotic resistance (MAR) analysis has been used to differentiate bacteria from different sources using antibiotics that are commonly used for human therapy. Compared to other metho bacteria source tracking such as genotypic characterization, the MAR indexing method is cost effective, rapid and easy to perform. It is also simple and does not require specialized training and expensive equipment [13] . The monitoring of both antibiotic consumption and multiple antibiotic resistances (MAR) especially in nosocomial infections is critically necessary to setting up of effective containment programs and audit of such programs [13, 15] .
Pseudomonas and Klebsiella are major pathogens in healthcare associated infections (HAI) [12] . This not only because of the attendant significant morbidity associated with infections but also because increasing rates of resistance in them is making it more difficult for them to be treated with cheaper first line antibiotics. Emerging and increasing resistance to newer and otherwise efficacious antibiotics may compound the whole problem [1] . The 30.9% and over 19% prevalence obtained for pseudomonas and klebsiella respectively out of a sample of 110 clinical isolates approximate to prevalence previously obtained in centre of study [11, 16] Blue bars represent proportion that is sensitive; Red bars represent proportion that is resistant.
High prevalence of multidrug resistance indicates a serious need for antibiotics surveillance program. Multiple antibiotic resistance (MAR) analysis has been used to differentiate bacteria from different sources using antibiotics that are commonly used for human therapy. Compared to other methods of bacteria source tracking such as genotypic characterization, the MAR indexing method is costeffective, rapid and easy to perform. It is also simple and does not require specialized training and expensive equipment [13] . The monitoring of iotic consumption and multiple antibiotic resistances (MAR) especially in nosocomial infections is critically necessary to setting up of effective containment programs and audit of such are major pathogens in healthcare associated infections (HAI) [12] . This not only because of the attendant significant morbidity associated with infections but also because increasing rates of resistance in them is making it more difficult for them to be treated with cheaper t line antibiotics. Emerging and increasing resistance to newer and otherwise efficacious antibiotics may compound the whole problem [1] . The 30.9% and over 19% prevalence obtained for respectively out of a isolates approximate to prevalence previously obtained in centre of study Isolates of both genera demonstrated high levels of susceptibility to the first three drugs (imipenem 32 (94.15%), genticin 19 (91.2%) and ciprofloxacin 29 (85.3%) for pseudomonas and imipenem Genticin 19 (90.5%), Ciprofloxacin 19 (90.5%) for klebsiella spp while varying levels of resistance from moderate to high levels resistance were demonstrated to the cephalosporins. This finding is consistent with that of other studies which reported low resistance profiles for the quinolones and aminoglycosides respectively [8, 12, 16] . However the difference in resistance rates in these works may be (in spite of general similar low rates profile for these drugs) explained by the increasing trend that had been noted globally [1] . This may have implications on the effectiveness of the local and probably national hospital infection and antibiotic resistance control programs. The moderate to high levels of resistance in the cephalosporins underscore the emergence of specifically cephalosporinases among resistant strains of these organisms as previously reported [2,6,10.14.15] . This compromises the clinical efficacy of a very important class of drugs commonly used in the management of many infections in this environment. The clearly visible high rate resistance of isolates to penicillin (Piperacillin, Carbenicillin) corroborates documented increasing penicillinase-producing B-lactamases these organisms [10] . Isolates of both genera demonstrated high levels of susceptibility to the first three drugs (imipenem 32 (94.15%), genticin 19 (91.2%) and ciprofloxacin 29 imipenem 20 (95.2%), Genticin 19 (90.5%), Ciprofloxacin 19 (90.5%) for while varying levels of resistance from moderate to high levels resistance were demonstrated to the cephalosporins. This finding is consistent with that of other studies which reported low resistance profiles for the quinolones and sides respectively [8, 12, 16] . However the difference in resistance rates in these works may be (in spite of general similar low rates profile for these drugs) explained by the increasing trend that had been noted globally [1] . This may have n the effectiveness of the local and probably national hospital infection and antibiotic resistance control programs. The moderate to high levels of resistance in the cephalosporins underscore the emergence of B-lactamases, mong resistant strains of these organisms as previously reported [2,6,10.14.15] . This compromises the clinical efficacy of a very important class of drugs commonly used in the management of many infections in this environment. The clearly visible high rate of resistance of isolates to penicillin (Piperacillin, Carbenicillin) corroborates documented increasing lactamases strains among Analysis of the MAR index of isolates showed that onas and Klebsiella
